Stock listing
NASDAQ:ACER Acer Therapeutics Inc Stock
Follow Acer Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ACER no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ACER
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Acer Therapeutics Inc on 6ix
- Decks
- 58 decks · latest Jun 26, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2023) | Investor deck | 26 slides | Jun 26, 2023 |
| Investor Presentation (March 2023) | Investor deck | 25 slides | Mar 27, 2023 |
| Investor Presentation (February 2023) | Investor deck | 36 slides | Feb 1, 2023 |
| Investor Presentation (January 2023) | Investor deck | 36 slides | Jan 5, 2023 |
| Investor Presentation (January 2023) | Investor deck | 33 slides | Jan 3, 2023 |
| Investor Presentation (August 2022) | Investor deck | 37 slides | Aug 23, 2022 |
| Investor Presentation (June 2022) | Investor deck | 34 slides | Jun 29, 2022 |
| Investor Presentation (May 2022) | Investor deck | 33 slides | May 16, 2022 |
| Investor Presentation (March 2022) | Investor deck | 33 slides | Mar 16, 2022 |
| Investor Presentation (October 2021) | Investor deck | 46 slides | Oct 14, 2021 |
Show 50 decks
This page holds 50 of 58 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jason Amello Other companies: TScan Therapeutics, Inc. (Chief Financial Officer · Since at least Jan 29, 2024); Candel Therapeutics, Inc. (Chief Financial Officer · Sep 21, 2022 – Nov 28, 2023 · Past); Akebia Therapeutics, Inc. (SVP, CFO & Treasurer · Apr 11, 2019 – Feb 28, 2020 · Past) | Director · Jan 2, 2020 – Mar 14, 2023 · Past |
| Michael Richman Other companies: NextCure, Inc. (President & CEO · Since at least May 8, 2019); GenVec Inc (Director · Nov 13, 2015 – Jun 16, 2017 · Past); Palvella Therapeutics, Inc. (Director · Jul 15, 2015 – Jun 21, 2023 · Past) | Director · Jun 30, 2015 – Sep 30, 2016 · Past |
| Michelle Griffin Other companies: Adaptive Biotechnologies Corporation (Board Member · Since at least Mar 6, 2023); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past) | Director · Mar 14, 2023 – Mar 14, 2023 · Past |
| Hubert Birner Other companies: Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past) | Director · Dec 12, 2017 – Aug 1, 2018 · Past |
| Steve Aselage Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 24, 2024 – Jun 12, 2024 · Past) | Director · Nov 17, 2023 – Nov 17, 2023 · Past |
| Bernard H Paul | Chief People Officer · Jan 14, 2022 – Mar 14, 2023 · Past |
| Harry S Palmin | CHIEF FINANCIAL OFFICER · Sep 19, 2017 – Nov 17, 2023 · Past |
| Jefferson E Davis | CHIEF BUSINESS OFFICER · Mar 14, 2023 – Nov 17, 2023 · Past |
Log in to ask 6ix AI your own questions about Acer Therapeutics Inc.